WhiteLab Genomics
Unleashing the potential of DNA and RNA based therapies using AI
About WhiteLab Genomics
We have developed an AI platform enabling to accelerate the discovery and the design of genomic therapies such as Cell Therapies, RNA Therapies and DNA Therapies.
Company details
Funding
Total raised
$10.6M
Last stage
Series A
Investors
Founders
Julien Cottineau
Senior application scientist at Genomic Vision, leading provider of genetic devices and platform Research fellow at Rockefeller Univ & Necker Hospital on human complex immune deficiencies in J-L Casanova’s lab PhD in genetics, molecular biology & immunology at Université Pierre & Marie Curie With Honors
David Del Bourgo
23 years of experience in healthcare innovation with multiple executive roles in Business Development, Marketing and Commercial Operations. Former GE Healthcare. MBA Chicago Booth, Biomedical Engineer MS University of Compiègne, France.
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.